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Abstract: Pericytes regulate the development of organ-specific characteristics of the brain vasculature such
as the blood-brain barrier (BBB) and astrocytic end-feet. Whether pericytes are involved in the control
of leukocyte trafficking in the adult central nervous system (CNS), a process tightly regulated by CNS
vasculature, remains elusive. Using adult pericyte-deficient mice (Pdgfb ret/ret ), we show that pericytes
limit leukocyte infiltration into the CNS during homeostasis and autoimmune neuroinflammation. The
permissiveness of the vasculature toward leukocyte trafficking in Pdgfb ret/ret mice inversely correlates
with vessel pericyte coverage. Upon induction of experimental autoimmune encephalomyelitis (EAE),
pericyte-deficient mice die of severe atypical EAE, which can be reversed with fingolimod, indicating that
the mortality is due to the massive influx of immune cells into the brain. Additionally, administration of
anti-VCAM-1 and anti-ICAM-1 antibodies reduces leukocyte infiltration and diminishes the severity of
atypical EAE symptoms of Pdgfb ret/ret mice, indicating that the proinflammatory endothelium due to
absence of pericytes facilitates exaggerated neuroinflammation. Furthermore, we show that the presence
of myelin peptide-specific peripheral T cells in Pdgfb ret/ret ;2D2 tg mice leads to the development
of spontaneous neurological symptoms paralleled by the massive influx of leukocytes into the brain.
These findings indicate that intrinsic changes within brain vasculature can promote the development of
a neuroinflammatory disorder.
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Pericytes regulate the development of organ-specific characteristics
of the brain vasculature such as the blood–brain barrier (BBB) and
astrocytic end-feet. Whether pericytes are involved in the control of
leukocyte trafficking in the adult central nervous system (CNS), a
process tightly regulated by CNS vasculature, remains elusive. Using
adult pericyte-deficient mice (Pdgfbret/ret), we show that pericytes
limit leukocyte infiltration into the CNS during homeostasis and au-
toimmune neuroinflammation. The permissiveness of the vasculature
toward leukocyte trafficking in Pdgfbret/ret mice inversely correlates
with vessel pericyte coverage. Upon induction of experimental auto-
immune encephalomyelitis (EAE), pericyte-deficient mice die of severe
atypical EAE, which can be reversed with fingolimod, indicating that
the mortality is due to the massive influx of immune cells into the
brain. Additionally, administration of anti-VCAM-1 and anti–ICAM-1
antibodies reduces leukocyte infiltration and diminishes the severity
of atypical EAE symptoms of Pdgfbret/ret mice, indicating that the
proinflammatory endothelium due to absence of pericytes facilitates
exaggerated neuroinflammation. Furthermore, we show that the pres-
ence of myelin peptide-specific peripheral T cells in Pdgfbret/ret;2D2tg
mice leads to the development of spontaneous neurological symptoms
paralleled by the massive influx of leukocytes into the brain. These
findings indicate that intrinsic changes within brain vasculature can
promote the development of a neuroinflammatory disorder.
pericyte | blood–brain barrier | leukocyte trafficking |
autoimmune neuroinflammation | MOG35–55–specific T cell receptor
Central nervous system (CNS) vasculature possesses specificfeatures collectively referred to as the blood–brain barrier
(BBB), which localizes to endothelial cells. The BBB ensures the
delivery of essential nutrients while preventing the entry of
xenobiotics into the brain. In addition, brain endothelial cells re-
strict the invasion of leukocytes into the brain parenchyma, thus
contributing to the immune privilege of the CNS. BBB function is
induced by neural tissue and established by all cell types consti-
tuting the neurovascular unit (NVU). Pericytes and mural cells
residing on the abluminal side of capillaries and postcapillary ve-
nules regulate several features of the BBB (1, 2). Studies on Pdgfb
and Pdgfrb mouse mutants, which exhibit variable pericyte loss,
have demonstrated that pericytes negatively regulate endothelial
transcytosis, which, if not suppressed, leads to increased BBB per-
meability to plasma proteins (1, 2). In addition, pericyte-deficient
vessels show abnormal astrocyte end-feet polarization (1). Thus,
pericytes regulate several characteristics of the brain vasculature
during development and in the adult organism (1, 2). Whether the
nonpermissive properties of the brain vasculature to leukocyte
trafficking in the adult organism are regulated by pericytes has not
been addressed. Interestingly, increasing evidence points to the role
of pericytes in leukocyte extravasation in peripheral organs such as
the skin and the striated muscle and in tumors (3–5).
Increased vascular permeability to plasma proteins and im-
mune cells accompanies neurological disorders such as multiple
sclerosis (MS), stroke, and Alzheimer’s disease (reviewed in refs.
6–8). In MS, a chronic inflammatory and degenerative neuro-
logical disorder (9), autoreactive lymphocytes infiltrate the CNS
parenchyma, leading to focal inflammatory infiltrates, demye-
lination, axonal damage, and neurodegeneration. These infil-
trating immune cells could induce vascular dysfunction, including
permeability to plasma proteins such as fibrinogen (10–12). On
the contrary, disruption of the BBB has been shown to precede
the infiltration of inflammatory cells and the formation of de-
myelinating lesions in MS patients (13). Therefore, it is impor-
tant to understand roles of different cell types and alterations in
cell–cell communication at the NVU, which may facilitate entry
of autoimmune T cells as well as the anatomical localization of
lesions. However, knowledge about how pericytes contribute to
the development of the disease is still limited.
This prompted us to investigate whether pericytes, which regu-
late several aspects of the BBB phenotype of endothelial cells, also
regulate immune cell trafficking into the CNS during homeostasis
and neuroinflammation. We show that pericytes play a crucial role
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in the regulation of BBB features related to the restricted leukocyte
trafficking into the CNS parenchyma, both under physiological and
pathophysiological conditions. We show that the permissiveness to
leukocyte trafficking into the CNS inversely correlates with the vessel
pericyte coverage, suggesting that vascular inflammation of the CNS
due to alterations in the cellular composition of the NVU can direct
the spatial distribution of neuroinflammation.
Results
Increased Expression of Leukocyte Adhesion Molecules in the Brain
Vasculature in Pericyte-Deficient Adult Mice. To address the ques-
tion of whether pericytes regulate immune cell trafficking into the
CNS, we used a pericyte-deficient mouse line, Pdgfbret/ret, which
shows ∼90% reduction in brain pericyte numbers and ∼75% re-
duction in pericyte vessel coverage in adult animals (1). Earlier
studies have shown that pericyte deficiency in embryos leads to
increased mRNA levels of leukocyte adhesion molecules (LAMs)
on endothelial cells (2). We analyzed published microarray data of
the adult Pdgfbret/ret brain microvasculature (1) and detected a
deregulation of several LAMs, including vascular cell adhesion
molecule 1 (VCAM-1; log2 = 0.43, P = 0.007), in the adult brain
microvasculature abated in pericyte numbers (SI Appendix, Fig.
S1A). To corroborate these findings, we investigated whether
strongly reduced pericyte coverage in adult mice leads to changes
of LAMs at the protein level. We focused on the expression of
VCAM-1 and intercellular adhesion molecule 1 (ICAM-1), which
play a major role in the cascade of immune cell transmigration
into tissues (14). We detected a zonated endothelial expression of
both LAMs in control mice (Fig. 1 A and B), similar to a published
study (15). In brains of Pdgfbret/ret mice, the zonated expression
pattern was lost and paralleled by a conspicuously stronger staining
of VCAM-1 and ICAM-1 (Fig. 1 A and B), which colocalized with
the endothelial marker podocalyxin (Fig. 1 C and D). Quantifica-
tion of VCAM-1 and ICAM-1 vessel surface coverage in the ce-
rebral cortex and in the striatum showed a significant increase of
VCAM-1 and ICAM-1 expression in Pdgfbret/ret mice compared
with controls (Fig. 1E). Thus, pericyte deficiency results in an in-
creased expression of LAMs on the brain vasculature in adult mice.
Leukocyte Extravasation into the Brain in Pericyte-Deficient Adult
Mice. We next asked whether increased expression of LAMs on


































Fig. 1. Increased expression of LAMs on pericyte-deficient brain vasculature. (A–D) Immunofluorescent stainings showing the expression of VCAM-1 (A) and
ICAM-1 (B) on brain vessels in the striatum of naïve control and pericyte-deficient mice (Pdgfbret/ret). Vascular basement membrane was visualized with
collagen IV (in green) and pericytes with CD13 (in cyan) immunostaining. High-magnification images of the vasculature of Pdgfbret/ret mice showing coloc-
alization of VCAM-1 (C) and ICAM-1 (D) staining (in magenta) with the endothelial marker podocalyxin (in green). (E) Quantification of vascular surface
coverage of VCAM-1 and ICAM-1 in the cortex and striatum in control and pericyte-deficient mice (Pdgfbret/ret; n = 3 mice per genotype). Unpaired t test was
used to determine statistical significance. Data are presented as the mean ± SD. (Scale bars: A and B, 100 μm; C and D, 50 μm.)
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by leukocyte infiltration into the brain parenchyma. We first
analyzed the presence of CD45hi leukocytes in different anatomical
regions of the brain by immunofluorescent staining and confocal
imaging. Adult Pdgfbret/ret mice showed numerous CD45hi leukocyte
infiltrates in the brain parenchyma (Fig. 2A). High-magnification
images revealed that CD45hi cells were found in the vessel lumen
and in the brain parenchyma and clustered around blood vessels in
the brains of Pdgfbret/ret mice, whereas, in control mice, CD45hi cells
were detected, but they resided in the lumen of blood vessels (Fig. 2
B and D). CD45hi leukocyte infiltrates can be distinguished from
CD45lo microglia based on their round morphology and the lack of
expression of the microglia marker P2Y12 (SI Appendix, Fig. S2A).
Microglia surrounding CD45hi infiltrates in corpus callosum in
Pdgfbret/ret mice show a slightly altered morphology of shorter and
thicker dendrites (SI Appendix, Fig. S2A), and occasional local al-
teration in microglia morphology was also detected in the cerebral
cortex (SI Appendix, Fig. S2B). Pdgfbret/ret mice show a slightly in-
creased number of microglia in the brain but not in the spinal cord
(SI Appendix, Fig. S2 C and D). Although all cerebral regions in
Pdgfbret/ret mice showed altered vascular expression of LAMs and
immune cell infiltrates, quantification of extravasated leukocytes in
different brain regions showed that corpus callosum and striatum
contained more transmigrated CD45hi cells compared with cortex
(Fig. 2C). Notably, immunohistochemical analysis of CD45hi cells in
the spinal cord of Pdgfbret/retmice showed the absence of immune cell
infiltrates in the spinal cord parenchyma (SI Appendix, Fig. S1B).
Having established that the brain parenchyma of Pdgfbret/ret mice
contains CD45hi cells, we used flow cytometry to identify immune
cell populations. To characterize immune cell populations, leuko-
cytes were isolated from the CNS and analyzed by flow cytometry.
Flow cytometric analysis confirmed the immunohistochemistry
findings and showed increased frequencies of CD45hi cells in the
CNS of pericyte-deficient mice. The majority of cells in the brains of
Pdgfbret/ret mice were CD45hiCD11b+ myeloid cells (mainly com-
posed of Ly6Chi monocytes and CD11c+MHC-IIhigh dendritic cells
[DCs]) and T cells (Fig. 2E). Quantification of the absolute cell
numbers of manually gated immune cell subsets in the brain showed a
significant increase in the number of CD45hiCD11b+ myeloid cells,
Ly6ChiMHC-II+ monocyte-derived cells (MdCs), Ly6Chi monocytes
(Ly6G−Ly6ChiMHC-II− myeloid cells), DCs (3.5% of the
CD45hiCD11b+ population), and CD4+ and CD8+ T cell populations
compared with controls (Fig. 2F). Similarly to immunohistochemical
analysis, no difference was detected in CD45hi cells in the spinal cord
between control and Pdgfbret/ret mice using flow cytometry analysis
(SI Appendix, Fig. S1 C and D).
We next investigated the temporal aspect of leukocyte infiltra-
tion. ICAM-1 expression was detected by the developing vascula-
ture in postnatal brains (postnatal day [P] 6, P16, P25) in control
and Pdgfbret/ret mice (SI Appendix, Fig. S3). We did not detect
CD45hi infiltrates in brain parenchyma at investigated postnatal
stages (P6, P16, P25) in Pdgfbret/ret mice; however, frequent CD45hi
cells were detected inside the vessel lumen in 16- and 25-d-
old Pdgfbret/ret mice (SI Appendix, Fig. S4). Thus, extravasation of
leukocytes into brain parenchyma in Pdgfbret/ret mice takes place after
P25, a time point when the angiogenesis has gradually diminished
and vasculature begins to stabilize (16).
Taken together, our data show that, in the absence of pericytes,
the adult brain vasculature becomes permissive for leukocyte entry
and that the infiltrated leukocyte population consists mostly of
Ly6Chi monocytes, MdCs, DCs, and T cells.
Characterization of Leukocyte Populations in Peripheral Organs in
Pericyte-Deficient Adult Mice. We next analyzed leukocyte pop-
ulations in blood as well as in primary and secondary lymphoid
organs to ensure that the increased number of leukocytes in the
brains of pericyte-deficient animals is not caused by peripheral al-
terations. The total cell number in thymus, spleen, axillary and
inguinal lymph nodes, and blood was determined using an auto-
mated cell counter with isolated cells stained for further flow
cytometry analysis. The cell number in the thymus, spleen, lymph
node, and blood was comparable between Pdgfbret/ret and control
mice (SI Appendix, Fig. S5A). Subsequent analysis of leukocyte
populations did not show a skewing between Pdgfbret/ret and control
mice in blood, lymph nodes, and spleen (SI Appendix, Fig. S5 B–D).
There was no difference in the total leukocyte or neutrophil count
in blood (SI Appendix, Fig. S5B), indicating the absence of systemic
inflammation in Pdgfbret/ret mice. Histological examination of lym-
phoid organs did not show any differences in the spatial organiza-
tion of T and B cells (SI Appendix, Fig. S5 E–G) between Pdgfbret/ret
and control mice.
We also investigated whether organs other than the brain pre-
sented with leukocyte infiltration or a spontaneous inflammation in
Pdgfbret/ret mice. Flow cytometry analysis of immune cell populations
was performed in the lung, liver, and small intestine of control and
Pdgfbret/ret mice. No difference in any of the analyzed immune cell
populations was observed between control and Pdgfbret/ret mice
(SI Appendix, Fig. S6).
Thus, the increased number of infiltrated leukocyte subsets in
the brain of adult pericyte-deficient mice is not due to increased
numbers in the blood or peripheral organs.
Spatial Differences in Pericyte Coverage in the CNS of Pdgfbret/ret
Mice. Previous studies have shown a negative correlation between
pericyte coverage and BBB permeability in the brain (1, 2, 17–19).
We therefore asked whether selective leukocyte infiltration into
different CNS regions in Pdgfbret/ret mice can be explained by dif-
ferences in capillary pericyte coverage in the brain and spinal cord.
Therefore, we determined pericyte coverage in several other brain
regions in addition to already reported areas (e.g., cortex and deep
brain regions) (1, 17). Pericyte coverage in Pdgfbret/ret mice was
significantly reduced also in the cerebellum and brainstem (∼42%
and ∼54%, respectively; SI Appendix, Fig. S7 A and B). In agree-
ment with reduced pericyte coverage, we observed a significantly
increased VCAM-1 and ICAM-1 coverage in the brainstem and
cerebellum of Pdgfbret/ret mice (SI Appendix, Fig. S7 C–F) and nu-
merous CD45hi cell infiltrates (SI Appendix, Fig. S7 G–J). Quan-
tification of vessel surface pericyte coverage in the spinal cord
showed that Pdgfbret/ret mice also have a significantly reduced cap-
illary pericyte coverage compared with control animals in this CNS
region (Fig. 3 A and B). However, the observed reduction (∼26%)
of pericyte coverage in the spinal cord vasculature of Pdgfbret/ret
mice is notably less than the previously reported reduction of
pericyte coverage in the cortex or deep brain regions (∼75%)
(1, 17) or in the brainstem and cerebellum (54% and 42%, re-
spectively; SI Appendix, Fig. S7 A and B). In agreement with rel-
atively complete pericyte coverage, the pattern and morphology of
spinal cord vasculature of Pdgfbret/ret mice appeared similar to
control mice (Fig. 3A). The difference in vessel pericyte coverage
between spinal cord and different brain regions in Pdgfbret/ret mice
indicates that spinal cord pericytes are less dependent on the
platelet-derived growth factor (PDGF) B–PDGF receptor β sig-
naling axis for vascular recruitment.
Finally, we investigated whether higher capillary pericyte coverage
in the spinal cord of Pdgfbret/ret mice parallels normalized expression
of VCAM-1 and ICAM-1. Indeed, the expression of VCAM-1 and
ICAM-1 on the spinal cord vasculature showed a similar zonal ex-
pression pattern in control and Pdgfbret/ret mice and only a slight in-
crease in VCAM-1 and ICAM-1 coverage (∼3–4%; Fig. 3 C–F).
Based on these data, we conclude that regional differences in
the degree of capillary pericyte coverage in the CNS determine
the extent to which the brain vasculature is permissive to leu-
kocyte entry into the CNS under homeostasis.
Török et al. PNAS | 3 of 12























































































































































Fig. 2. Increased extravasation of leukocytes in the brain parenchyma of naïve pericyte-deficient brain. (A) Overview images of the periventricular areas in
the brains of control and pericyte-deficient mice (Pdgfbret/ret). Arrowheads indicate leukocyte infiltrates (CD45, in red) in the parenchyma of Pdgfbret/ret mice.
Blood vessels are visualized by collagen IV staining (in green). (B) High-magnification images showing a parenchymal infiltrate of CD45hi leukocytes (in red,
asterisk) in the corpus callosum of Pdgfbret/ret mice. In control mice, few CD45hi leukocytes (arrowheads) are found only in the lumen of blood vessels
(podocalyxin, in green). (C) Quantification of CD45hi leukocytes in different anatomical regions in the brains of control and Pdgfbret/ret mice (n = 3). (D)
Quantification of extravasated CD45hi leukocytes in different anatomical regions in the brains of control and Pdgfbret/ret mice (n = 3). One-way ANOVA
followed by Tukey’s post hoc test was used to determine the statistical significance. (E) Representative flow-cytometry pseudocolor plots showing the manual
gating of microglia and other immune cell populations in the brain of naïve control and Pdgfbret/ret mice. (F) Quantification of the absolute cell numbers of
detected immune cell populations using flow cytometry in the brain (n = 7–8 mice per genotype). Pooled data from two independent experiments. Statistical
significance was determined using unpaired t test (DCs, CD11c+, MHC-IIhigh, and CD4+ and CD8+ T cells) or Mann–Whitney U test (CD45hi cells, CD45hiCD11b+
cells, MdCs, Ly6Chi monocytes, neutrophils, and B cells). Data are presented as the mean ± SD. (Scale bars: A, 250 μm; B, 100 μm; Insets, 20 μm.)
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Loss of Pericytes Does Not Alter Myelin Integrity. We next asked
whether increased BBB permeability to plasma proteins (1, 2) and
leukocytes leads to subclinical demyelination in the brains of
pericyte-deficient mice. Myelin was visualized using Luxol fast
blue–periodic acid Schiff (LFB-PAS) histochemical stains and
immunofluorescent labeling with anti-myelin basic protein (MBP)
antibody (SI Appendix, Fig. S8 A and B). Quantification of LFB-
PAS and anti-MBP staining intensity in the region of high myelin
content, the corpus callosum, did not differ between control and
Pdgfbret/ret mice (SI Appendix, Fig. S8 B–D). A few brain sections of
Pdgfbret/ret mice stained with LFB-PAS had a reduced staining in-
tensity (score of 1) in the corpus callosum due to accompanying
brain edema (1); however, demyelinating lesions were absent in
the analyzed brain areas. Additionally, we did not detect differ-
ences in the ultrastructure of the myelin sheath between Pdgfbret/ret


























































































Fig. 3. Pericyte coverage and expression of LAMs in the spinal cord vessels of Pdgfbret/ret mice. (A) Immunofluorescent staining of pericytes (CD13, in cyan)
and vasculature (collagen IV, in red) in different anatomical regions of the CNS (spinal cord, striatum, cortex) in control and Pdgfbret/ret mice. The yellow
dotted line outlines the cortical surface. (B) Quantification of vessel pericyte coverage in the spinal cord of control and Pdgfbret/ret mice (n = 3 mice per
genotype). (C and D) VCAM-1 (C) and ICAM-1 (D) expression (in cyan) on the blood vessels (in red, collagen IV) in the spinal cord of control and Pdgfbret/ret
mice. (E and F) Quantification of vascular surface coverage of VCAM-1 (E) and ICAM-1 (F) in the spinal cord of control and Pdgfbret/ret mice. (Scale bars:
100 μm.) Unpaired t test was used to determine statistical significance.
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Thus, infiltrated leukocytes in brain parenchyma in pericyte-
deficient mice do not initiate demyelinating pathology.
Pericyte-Deficient Mice Present an Aggravated, Atypical Experimental
Autoimmune Encephalomyelitis Phenotype. We next investigated
whether leukocyte-permissive vasculature modifies the course of
autoimmune neuroinflammation. In order to address this ques-
tion, we induced experimental autoimmune encephalomyelitis
(EAE), an animal model of MS (20), in control and Pdgfbret/ret
mice. After active induction of EAE, which replicates both the
induction and effector phase of the disease, Pdgfbret/ret mice pre-
sented with a severe, early-onset (4–5 d postimmunization) atyp-
ical phenotype as well as reduced survival (Fig. 4 A and B and SI
Appendix, Fig. S9A and Table S2). We confirmed that control
animals (Pdgfbwt/ret) did not differ from wild-type littermates in the
clinical course of EAE (SI Appendix, Fig. S9 B and C). Therefore,
Pdgfbwt/ret mice were continued to be used as controls. All control
mice presented typical spinal cord EAE symptoms with ascending
paralysis starting at the distal tail. All Pdgfbret/ret mice invariably
developed atypical phenotype, which consisted of prominent cer-
ebellar ataxia and spasticity, without ascending paralysis. To score
the clinical severity of EAE in Pdgfbret/ret mice, we adopted an ataxia
scoring protocol described by Guyenet et al. (21). We noticed that
Pdgfbret/ret mice presented with a basal ataxia score of 2 already
at day 0, which consisted of kyphosis (score of 1) and hindlimb
clasping (score of 1; Fig. 4B; scoring protocol described in Materials
and Methods). Adoptive transfer (passive) EAE resulted in the
same aggravated atypical EAE in Pdgfbret/ret mice as seen in active
EAE (Fig. 4C), indicating that the severe phenotype is not due to a
pathologically enhanced induction phase in pericyte-deficient mice.
Immunization with a non-CNS antigen (ovalbumin peptide) using
the same adjuvant did not result in clinical deficits in control or
Pdgfbret/ret mice (SI Appendix, Fig. S9D).
We next investigated the spatial distribution of infiltrating
cells in the CNS after induction of EAE using immunohisto-
chemistry. This analysis showed an increased leukocyte infiltra-
tion into the brain parenchyma (cerebral cortex, striatum, corpus
callosum, cerebellum, brainstem) of Pdgfbret/ret animals, whereas
immune cell infiltrates were mostly found in the spinal cord in
control animals (Fig. 4 D and E and SI Appendix, Fig. S9 E and
F). The spinal cords of pericyte-deficient animals were devoid of
T cell infiltrates, consistent with the atypical clinical phenotype
(Fig. 4E) and with relatively complete vessel pericyte coverage
(Fig. 3). Assessment of myelin damage after the induction of
EAE showed pronounced demyelination in the brains of
pericyte-deficient mice compared with control animals (SI Ap-
pendix, Fig. S9 G and H).
We next analyzed which immune cells infiltrate the CNS after
active immunization in control and Pdgfbret/ret mice. Flow cytometry
analysis confirmed the immunohistochemistry results showing an
increased number of CD45hi leukocytes in the brains in Pdgfbret/ret
mice compared with controls (Fig. 4F and SI Appendix, Fig. S10A).
The majority of these infiltrates (approximately 60% of live sin-
glets) in Pdgfbret/ret mice were CD45hiCD11b+ myeloid cells. Within
this population, we detected a significant increase of Ly6Chi
monocytes and MdC subpopulations in the brains of Pdgfbret/ret
mice compared with controls but no differences in neutrophil or
B cell numbers (Fig. 4F and SI Appendix, Fig. S9I). In agreement
with the clinical deficits and immunohistochemistry, the spinal cord
of Pdgfbret/ret mice was essentially devoid of leukocytes compared
with controls (Fig. 4G and SI Appendix, Figs. S9J and S10B).
Thus, Pdgfbret/ret mice develop a severe, atypical EAE phenotype
and show spatially restricted infiltration of inflammatory cells pre-
dominantly into the brain, consisting mostly of Ly6Chi monocytes
and MdC populations.
MS Drug Fingolimod (FTY-720) Ameliorates the Severe Atypical EAE
Phenotype of Pdgfbret/ret Mice. We next addressed whether the
aggravated phenotype of Pdgfbret/ret mice after induction of EAE
is caused by the massive influx of peripheral immune cells into
the CNS. Mice were treated daily, starting on day 4 postimmunization,
with FTY-720 (fingolimod), a functional antagonist of sphingosine-
1-phosphate receptor 1 (S1P1), which causes leukopenia by blocking
the egress of lymphocytes from lymph nodes (22). All vehicle-treated
Pdgfbret/ret mice reached termination criteria (ataxia score of 8.5–10)
after EAE induction, whereas FTY-720–treated Pdgfbret/ret mice did
not develop symptoms of EAE during the course of the experiment
(25 d; Fig. 5 A and B). Of note, the ataxia score of 2 observed in all
Pdgfbret/ret mice before FTY-720 administration was not alleviated by
FTY-720 treatment. As expected, the EAE score of vehicle-treated
control animals improved by day 25 postimmunization. In addition,
FTY-720–treated control mice did not develop EAE (Fig. 5B and SI
Appendix, Fig. S11A). Flow cytometry analysis of peripheral blood
on day 12 postimmunization with MOG peptide confirmed the
FTY-720 treatment-induced leukopenia in control and Pdgfbret/ret
mice (SI Appendix, Fig. S11 B–E). Flow cytometric analysis of
immune cells in the brains and spinal cords of vehicle- and FTY-
720–treated Pdgfbret/ret mice was performed on the same day when
vehicle-treated mice reached termination criteria (ataxia score of
8.5–10). In parallel, brains and spinal cords of vehicle- and FTY-
720–treated control mice were analyzed on the same day when
vehicle-treated control mice reached EAE score of 3–3.5. As
expected, FTY-720–treated animals had significantly lower num-
bers of CD45hi immune cells in the CNS both in control and
Pdgfbret/ret mice (Fig. 5 C and D and SI Appendix, Fig. S11 F and
G). In addition to reduced number of CD4+ and CD8+ T cells, we
also observed a reduction of myeloid cells (Ly6Chi monocytes and
MdCs) after FTY-720 treatment in the brains of Pdgfbret/ret mice.
FTY-720 treatment after the induction of EAE has been shown to
reduce the number of circulating monocytes in addition to T cells
(23), which could explain the significantly reduced myeloid cells in
the spinal cord of control mice as well as in the brains of both
control and Pdgfbret/ret mice (Fig. 5 C and D and SI Appendix, Fig.
S11 F and G). Immunohistochemical analysis confirmed the re-
duced infiltration of leukocytes into the brain of pericyte-deficient
mice after FTY-720 treatment (SI Appendix, Fig. S11H).
Thus, we conclude that the mortality of pericyte-deficient mice
after induction of EAE is caused by excessive entry of peripheral
immune cells into the brain and neuroinflammation.
Combined Anti–VCAM-1 and Anti–ICAM-1 Treatment Mitigates the Severe
Atypical EAE Phenotype of Pdgfbret/ret Mice. Pericyte deficiency alters
endothelial cell phenotype and leads to up-regulation of LAMs on
the brain endothelium, which are important for leukocyte transmi-
gration. We therefore addressed whether the massive infiltration of
leukocytes can be modulated by blocking ICAM-1 and VCAM-1
after the induction of EAE, and whether this will alter the course of
the disease. Mice were treated daily with a mix of anti–VCAM-1
and anti–ICAM-1 monoclonal antibodies starting on day 1 post-
immunization. Control mice treated with isotype control reached
termination criteria (EAE score of 3–3.5), while control mice
treated with anti–VCAM-1 and anti–ICAM-1 antibodies devel-
oped no symptoms or milder symptoms that stagnated (Fig. 6A).
All IgG isotype control-treated Pdgfbret/retmice reached termination
criteria similarly to previous experiments, whereas anti–VCAM-1
and anti–ICAM-1 treatment ameliorated the ataxia symptoms and
rescued the mortality of Pdgfbret/ret mice (Fig. 6 B and C). In
agreement with this improved phenotype, flow cytometric analysis
showed a significant reduction in the total number of CD45hi
leukocytes in the brains of Pdgfbret/retmice and in the spinal cords of
control mice treated with anti–VCAM-1 and anti–ICAM-1 anti-
bodies compared with isotype control-treated mice (Fig. 6 D and E
and SI Appendix, Fig. S12).
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Thus, blocking LAMs on the endothelium alleviated the severe
clinical phenotype of pericyte-deficient mice, indicating that the
proinflammatory phenotype of the endothelium caused by pericyte
deficiency contributes to the aggravated leukocyte extravasation
during neuroinflammation.
Spontaneous Neuroinflammation in Pdgfbret/ret Mice Expressing
Myelin-Specific T Cell Receptor. Little is known about what triggers
spontaneous activation and entry of self-reactive T cells into the
CNS. We asked whether the leukocyte-permissive NVU in pericyte-
deficient animals leads to spontaneous neuroinflammation when
there is an overabundance of self-reactive T cells toward a myelin
antigen. To answer this question, we crossed Pdgfbret/retmice with 2D2
mice, which express a MOG35–55 peptide-specific T cell receptor
(TCR) (24). Previous studies have reported that ∼5% of 2D2 mice
develop spontaneous EAE with classical symptoms (24). Offspring of
Pdgfbret/ret and Pdgfbwt/ret;2D2tg crosses were monitored after weaning
for signs of cerebellar ataxia and classical EAE. Consistent with
previous observations (Figs. 4B, 5B, and 6C), all animals carrying two
alleles of mutated Pdgfb (Pdgfbret/ret) presented with an ataxia score of
2, consisting of hindlimb clasping (score of 1) and kyphosis (score of










































Fig. 4. Pericyte-deficient mice die with atypical EAE accompanied by increased leukocyte infiltration into the brain. (A) Kaplan–Meier survival curves after
active induction of EAE. The experiment was terminated on day 15, indicated by black dashed line. Pooled data from two individual experiments (n = 11 mice
per genotype). Survival curves showed statistical difference (P < 0.0001, log-rank test). (B) Scoring of neurological symptoms during the course of active EAE.
The left y axis shows cerebellar ataxia scores of Pdgfbret/ret mice (in red), and the right y axis shows classical EAE scores of control mice (in black). Arrowheads
indicate when individual mice were euthanized for flow-cytometry analysis. Materials and Methods includes detailed termination criteria. Each line repre-
sents symptoms of an individual mouse (n = 5 mice per genotype, showing two pooled experiments). (C) Kaplan–Meier survival curves after passive induction
of EAE. The experiment was terminated on day 14, indicated by black dashed line (controls, n = 5; Pdgfbret/ret, n = 6). Survival curves showed a statistically
significant difference (P = 0.0300, log-rank test). (D) Immunohistochemical staining of T cells (CD3, in red) of sagittal brain sections of the cerebellum and
brainstem after active induction of EAE of control (on day 16 postimmunization) and Pdgfbret/ret mice (on day 11 postimmunization). (E) Immunohisto-
chemical staining of T cells (CD3, in red) on coronal sections of the spinal cords showing two regions (1, 2) after active induction of EAE in control (on day 16
postimmunization) and Pdgfbret/ret mice (on day 11 postimmunization). Tissue sections were counterstained with hematoxylin (D and E). (F and G) Quanti-
fication of the absolute cell numbers of different leukocyte populations (gated as shown in SI Appendix, Fig. S10) in the brains (cerebrum, cerebellum, and
brainstem; F) and spinal cords (G) of control (EAE score of 3–3.5) and Pdgfbret/ret (ataxia score, n = 9–10) mice using flow cytometry. Shown are pooled data
from two individual experiments (n = 5 mice per genotype). Data are presented as the mean ± SD. Statistical significance was determined using unpaired
t test (brain, CD45hi, MdCs, and CD4+ T and CD8+ T cells; spinal cord, CD4+ T and Ly6Chi monocytes) or Mann–Whitney U test (brain, Ly6Chi monocytes; spinal
cord, CD45hi, CD8+ T cells, and MdCs). (Scale bars: D and E, 100 μm.)
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Pdgfbret/ret;2D2tg mice showed increasing cerebellar ataxia scores
compared with Pdgfbret/ret;2D2neg mice (Fig. 7A). Other control
mice (Pdgfbwt/ret;2D2neg, Pdgfbwt/ret;2D2tg) occasionally received a
score of 1, which was based on single balance loss on the ledge
test. Of note, the ataxia scores of individual Pdgfbret/ret;2D2tg mice
fluctuated over the monitored time period. None of the mice
developed signs of classical EAE. Immunofluorescent staining of
the brains of 3-mo-old Pdgfbret/ret;2D2tg animals showed an increased
number of CD45hi-positive cells in the brains compared with
Pdgfbret/ret;2D2neg mice (Fig. 7B). In support of this finding, flow
cytometric analysis confirmed that the brains of Pdgfbret/ret;2D2tg mice
contained a significantly higher number of CD45hi cells compared
with Pdgfbret/ret;2D2neg mice (Fig. 7C and SI Appendix, Fig. S13A).
Pdgfbret/ret;2D2tg animals and all control animals were euthanized for
flow cytometry when Pdgfbret/ret;2D2tg animals had reached the ataxia
score of 6–9. Immune cell infiltrates in the brains of Pdgfbret/ret and
Pdgfbret/ret;2D2tg mice consisted of Ly6Chi monocytes, MdCs, and
CD4+ and CD8+ T cells (Fig. 7C). Interestingly, in Pdgfbret/ret;2D2tg
mice, in addition to the aforementioned populations, neutrophils
and B cells were also detected. Furthermore, spinal cords of
Pdgfbret/ret;2D2tg mice showed a significant increase in immune
cell infiltrates; however, the total cell numbers were low com-
pared with brains (SI Appendix, Fig. S13 B and C).
Thus, these experiments demonstrate that the leukocyte-
















Fig. 5. FTY-720 treatment rescues the lethality of pericyte-deficient mice after induction of EAE. (A) Kaplan–Meier survival curves of vehicle and FTY-
720–treated Pdgfbret/ret mice after active induction of EAE (P = 0.002, log-rank test). The experiment was terminated on day 25 (marked by a black dashed
line; n = 5 mice treated with vehicle, n = 6 mice treated with FTY-720). (B) Scoring of clinical symptoms during the course of FTY-720 treatment after induction
of active EAE of control and Pdgfbret/ret mice. The left y axis shows the cerebellar ataxia scores of Pdgfbret/ret mice (in red) and the right y axis the classical EAE
scores of control mice (in black). FTY-720 administration (0.5 mg/kg) was started on day 4 postimmunization (black arrow), and the experiment was ter-
minated on day 25 postimmunization. The ataxia score or EAE score of each mouse is plotted individually. Arrowheads indicate when Pdgfbret/ret mice reached
termination criteria and were euthanized (n = 4–5 mice per group). (C and D) Quantification of the absolute cell numbers of the different immune cell
populations (gating shown in SI Appendix, Fig. S11 F and G) in the brain (C) and spinal cords (D) of vehicle- and FTY-720–treated control and Pdgfbret/ret mice
using flow cytometry. Controls, n = 3 vehicle-treated and n = 4 FTY-720–treated; Pdgfbret/ret mice, n = 3 vehicle-treated and n = 3 FTY-720–treated. Pooled
data from two independent experiments. Data are presented as the mean ± SD. Two-way ANOVA followed by Šídák’s post hoc test was used to determine
statistical significance between groups.
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the development of a neuroinflammatory disorder associated with
increased myelin-reactive T cells in the circulation.
Discussion
Pericytes have been shown to regulate BBB integrity at the level of
endothelial transcytosis (1, 2). Pericytes also induce polarization of
astrocyte end-feet (1); however, the extent of pericyte control over
other characteristics of the brain vasculature is less explored. In this
study, we investigated the role of pericytes in regulating leukocyte
trafficking into the adult CNS. In addition, we show that, in the absence
of pericytes, the NVU becomes permissive to leukocyte entry, leading
to aggravated neuroinflammation in a setting of autoimmunity.
A previous study on pericyte-deficient Pdgfb−/− embryos showed
that several LAMs (e.g., Icam1, Alcam, Lgals3) were significantly
up-regulated on the brain vasculature (2). In addition, a modest
increase in Ly-6G/Ly-6C–positive leukocytes was observed in the
brains of juvenile PdgfbF7/F7 mice that display a 50% reduction in
pericyte coverage compared with controls (2). Our observation
that several LAMs, including VCAM-1 and ICAM-1, are up-
regulated in the adult vasculature of Pdgfbret/ret mice, which is ac-
companied by increased leukocyte entry into the brain paren-
chyma, corroborates and extends these findings. The up-regulation
of VCAM-1 and ICAM-1 are important steps of the cascade of
















Fig. 6. Combined treatment using anti–VCAM-1 and anti–ICAM-1 antibodies ameliorates symptoms of pericyte-deficient and control mice after the in-
duction of EAE. (A) Scoring of clinical symptoms during the course of anti–VCAM-1 and anti–ICAM-1 mAb treatment after induction of active EAE of control
mice. (B) Kaplan–Meier survival curves of isotype control and anti–VCAM-1 and anti–ICAM-1 monoclonal antibody (α-VCAM-1 and α-ICAM-1 mAb) treated
Pdgfbret/ret mice after active induction of EAE (P = 0.05, log-rank test). (C) Scoring of clinical symptoms during the course of anti–VCAM-1 and anti–ICAM-1
mAb treatment after induction of active EAE in Pdgfbret/ret mice (C). (A–C) The EAE or ataxia score of each mouse is plotted. Arrowheads indicate when mice
reached termination criteria and were euthanized for analysis. The experiment was terminated on day 20 (black dashed line; n = 4 mice treated with isotype
control, n = 4 mice treated with anti–VCAM-1 and anti–ICAM-1 mAb). (D and E) Quantification of the absolute cell numbers of different immune cell
populations (gating shown in SI Appendix, Fig. S12) in the brains (D) and spinal cords (E) of isotype control and anti–VCAM-1 and anti–ICAM-1 mAb-treated
control and Pdgfbret/ret mice using flow cytometry. Controls, n = 4 mice per group; Pdgfbret/ret mice, n = 3 mice per group. Pooled data from two independent
experiments. Data are presented as the mean ± SD. Two-way ANOVA followed by Šídák’s post hoc test was used to determine statistical significance
between groups.
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natalizumab, a humanized monoclonal antibody against α4-integrin
on leukocytes, has been proven to be an effective treatment in MS
(25). However, no treatment blocking leukocyte entry on the en-
dothelial side has been approved as of today in the therapy of MS.
Treatment of Pdgfbret/ret mice with a mix of anti–VCAM-1 and
anti–ICAM-1 ameliorated EAE, rescued the mortality of pericyte-
deficient mice with 75% efficacy, and reduced the number of
infiltrated leukocytes. These findings corroborate that the proin-
flammatory phenotype of the brain endothelium of pericyte-deficient
mice substantially contributes to the massive leukocyte infiltration
during neuroinflammation. However, combined treatment was not
sufficient to abolish symptoms of pericyte-deficient mice, and it is
likely that additional changes at the NVU induced by the absence of
pericytes might contribute to the observed severe phenotype. En-
dothelial cells up-regulate Angiopoietin 2 (Angpt2) in the absence of
pericytes (1, 2), and neutralizing antibodies to Angpt2 reduce vas-
cular leakage and microaneurysm formation in the retina caused by
pericyte deficiency (26). Blocking of Angpt2 also ameliorates EAE
by suppressing vascular inflammation and leakage of plasma proteins
(27). Thus, it is plausible that a deregulated Ang2–Tie2 signaling axis
in endothelial cells in the absence of pericytes contributes to the
aggravated neuroinflammation in Pdgfbret/ret mice. Astrocyte end-feet































Fig. 7. Pericyte-deficient mice expressing myelin-specific TCR develop neurological symptoms accompanied by immune cell infiltration. (A) Scoring of cer-
ebellar ataxia in Pdgfbret/ret × Pdgfbwt/ret;2D2tg crossing offspring. Dashed black line indicates the mean baseline score of control mice (ataxia score 1, oc-
casional slip during the ledge test; n = 7–11 mice per genotype). (B) Immunofluorescent detection of CD45hi leukocyte infiltrates and microglia (in red) in the
striatum in Pdgfbret/ret;2D2neg and Pdgfbret/ret;2D2tg mice. Blood vessels are in green (collagen IV). (C) Representative flow cytometry pseudocolor plots
showing the manual gating of microglia and other immune cell populations in the brain. (C) Quantification of absolute cell numbers of immune cells (gated
as shown in SI Appendix, Fig. S13A) in the brains of control mice and Pdgfbret/ret;2D2neg and Pdgfbret/ret;2D2tg animals. Pdgfbret/ret;2D2tg mice were euthanized
at the peak of cerebellar ataxia symptoms (ataxia score of 6–9). Age of animals was 2–3 mo (C). Pooled data from four individual experiments. Data are
presented as the mean ± SD. One-way ANOVA followed by Tukey’s post hoc test was used to determine the statistical significance. (Scale bars: 100 μm.)
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serve yet another barrier limiting leukocyte entry during neuro-
inflammation (28, 29). Pericyte deficiency leads to a polarization
defect of astrocyte end-feet (1), which may also facilitate the in-
creased leukocyte trafficking in the absence of pericytes. Also, the
vascular basement membrane limits the entry of autoreactive T cells
into the CNS (30), and, since pericytes secrete and deposit compo-
nents of the vascular basement membrane (15), subtle alterations in
the organization and composition of the vascular basement mem-
brane could weaken its barrier function. In addition, increased vas-
cular permeability to plasma proteins (e.g., fibrinogen) due to
increased transcytosis in pericyte-deficient mice could contribute to
leukocyte trafficking. Thus, the mechanism by which pericytes
control leukocyte extravasation is likely multifaceted, and the in-
creased leukocyte trafficking and aggravated neuroinflammation in
pericyte-deficient mice is caused by a combination of changes in
acellular (basement membrane, increased presence of plasma proteins
in the brain parenchyma) and cellular components (endothelium, as-
trocytes) of the NVU (SI Appendix, Fig. S14A).
Similar persistent inflammation in the absence of pericytes as in
the brain vasculature in Pdgfbret/ret mice has been described in the
retina (26, 31–33). Published data on whether an acute dropout of
pericytes in the adult organism leads to altered BBB permeability
and alters the permissiveness of vasculature to leukocyte traf-
ficking are conflicting and need further study (26, 34). It has been
observed that CNS vasculature compensates to a certain extent for
pericyte loss and reduced pericyte coverage. Upon pericyte loss in
the brain, the area covered by a single pericyte can be filled by
spatial rearrangement of nearby pericytes (35). Increased BBB
permeability to intravenous tracers in juvenile PdgfbF7/F7 and
PdgfbF7/− mice that have a 50–60% reduction in pericyte coverage
is absent in adult animals (2), and up to 50% reduction in pericyte
vessel coverage in adult mice does not lead to overt BBB per-
meability changes (1) (SI Appendix, Fig. S14B). The loss of peri-
cytes may be compensated by other cells of the NVU such as
astrocytes, which have been shown to promote BBB integrity and
CNS immune quiescence (28, 36). Thus, in adult vasculature, which
has established structures (e.g., basement membrane and astrocyte
end-feet), pathological changes upon pericyte loss may develop
gradually over time. Notably, an increased infiltration of leukocytes
into the brain parenchyma has been reported in mouse pups that
express one allele of constitutively active PDGFRB, which alters
pericyte differentiation (37), indicating that both altered pericyte
numbers/vessel coverage and activation state (37, 38) disturb
pericyte-endothelial signaling. In the normal CNS, this disturbed
signaling limits immune surveillance.
Increased infiltration of immune cells into the brain parenchyma
in adult Pdgfbret/ret is not accompanied by demyelination. This
finding indicates that the permissive state of the brain vasculature to
immune cell entry is not sufficient to trigger demyelinating CNS
pathology. Normal oligodendrocyte differentiation and myelination
of adult Pdgfbret/ret mice been reported in a recent study (39). The
findings of our study contradict a previous report of white matter
changes and loss of myelin in another mouse model of pericyte
deficiency, PdgfrbF7/F7 mice (40). Whereas pericytes and pericyte-
like cells have been shown to proliferate and promote oligoden-
drocyte differentiation during remyelination after acute CNS injury
(39), mechanisms other than pericyte loss (i.e., dysfunction of neural
cell types expressing PDGFRB) in old Pdgfrb mutants could con-
tribute to the reported white matter changes during aging (40).
Cellular composition of infiltrated leukocytes could modify the
clinical course of neuroinflammation in pericyte-deficient mice.
Brain-restricted neuroinflammation is dominated by myeloid cells
(CD45hiCD11b+, approximately 87%) in Pdgfbret/ret mice during
EAE. Increased number of myeloid cells could lead to an aggra-
vated neuroinflammatory phenotype in Pdgfbret/ret mice. Increasing
evidence points to the key role of myeloid cell subsets in mediating
tissue damage in EAE and MS (reviewed in refs. 41, 42). Infil-
tration of CCR2+Ly6Chi inflammatory monocytes from the blood
into the CNS parenchyma coincides with the onset of the clinical
signs and worsens the severity of EAE (43–46).
The localization of demyelinating lesions in MS patients shows a
variable pattern. Typical affected areas are cerebral white matter
(e.g., periventricular, corpus callosum), brainstem, and cerebellum
(47). In the case of neuromyelitis optica spectrum disorders, another
type of autoimmune demyelinating disease, the optic nerve and
spinal cord are preferentially damaged (48). In EAE, a “classical”
spinal cord phenotype (ascending flaccid paralysis) can be distin-
guished from “atypical“ EAE with inflammation localized to the
cerebrum, cerebellum, and brainstem. The underlying mechanisms
leading to regional differences in leukocyte extravasation are not
well understood. It has been suggested that the brain and spinal
cord are distinct microenvironments with a distinct inflammatory
cell repertoire, including different T cell types and different cyto-
kines (49–52). We found that, upon induction of autoimmune
neuroinflammation, Pdgfbret/ret mice succumb to an atypical EAE.
In addition, Pdgfbret/ret;2D2tg animals presented fluctuating symp-
toms of cerebellar ataxia, milder than after the induction of EAE.
Histological and flow cytometry analyses of infiltrated immune
cells, which showed neuroinflammation localized to the brain in
pericyte-deficient mice, were in concordance with the clinical
deficits. We showed that, although the vessel pericyte coverage is
reduced in the spinal cord of Pdgfbret/ret mice compared with con-
trols, pericyte vessel coverage in the spinal cord in Pdgfbret/ret mice is
more complete compared with the brain (1, 17). This relatively
spared vasculature of spinal cord vessels with a higher pericyte
coverage and relatively small upregulation of ICAM-1 and VCAM-
1 (∼3–4%) compared with brain vessels could explain the prefer-
ential location of neuroinflammation in the brain in Pdgfbret/ret and
Pdgfbret/ret;2D2tg mice.
BBB breakdown, one of the pathological hallmarks of MS (53,
54), is an early event in the formation of the inflammatory lesions
and has been suggested to precede parenchymal inflammation
(55). Interestingly, one of the early changes after induction of
EAE, increased transcytosis of brain capillary endothelial cells,
leads to increased vessel permeability (56). Pericyte damage (e.g.,
lipofuscin accumulation, membrane protrusions) has been de-
scribed in chronic-progressive MS lesions (57). It has been sug-
gested that the BBB becomes disrupted by early inflammatory
microlesions via IL-1β (58) produced by MdCs and neutrophils
after EAE induction (59). However, the nature of changes at the
NVU that precede immune cell entry and cause failure of vascular
immune regulatory function in MS is not known. Our study shows
that intrinsic changes in the brain vasculature in mice facilitate the
neuroinflammatory cascade and can influence the localization of
the neuroinflammatory lesions. In the future, it would be inter-
esting to investigate early changes in the brain vasculature of MS
patients and determine whether vascular alterations regulate the
localization of MS lesions. Since vascular dysfunction modulates
leukocyte entry and neuroinflammation, vasoprotective therapies
combined with preexisting treatments could lead to improved
clinical outcomes in MS.
Materials and Methods
Transgenic mouse lines, reagents, immunohistochemistry and histochemistry,
flow cytometry and data analysis, induction of EAE and scoring, FTY-720,
anti–VCAM-1 and anti–ICAM-1 treatment, quantification of immunohisto-
chemical and histochemical stainings, transmission electron microscopy,
leukocyte isolation from tissues, and statistical analysis are described in
SI Appendix, Materials and Methods.
Data Availability All relevant data are included in the article and/or
SI Appendix.
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